Description
| COMPOSITION: | Each uncoated mouth dissolving tablet contains Voglibose 0.2 mg + Glimepiride 2 mg + Metformin Hydrochloride 500 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Vogliway GM2 15 Tablets contains Voglibose 0.2 mg + Glimepiride 2 mg + Metformin Hydrochloride 500 mg, an alphaglucosidase inhibitor that acts by stopping the absorption of sugars from intestine, thus controls blood sugar level. It is prescribed for type II diabetes alone or in combination with other drugs and controls. |
| SIDE EFFECTS: | Diarrhoea, loose stools, abdominal pain, constipation, anorexia, nausea, vomiting or heartburn may occur with the use of Voglibose. |
| DOSAGE/DIRECTIONS FOR USE: | AS PRESCRIBED BY PHYSICIAN |
Reviews
There are no reviews yet.